UA56458A - Раствор для консервирования донорской крови "адглюфоцит" - Google Patents
Раствор для консервирования донорской крови "адглюфоцит" Download PDFInfo
- Publication number
- UA56458A UA56458A UA2002054356A UA2002054356A UA56458A UA 56458 A UA56458 A UA 56458A UA 2002054356 A UA2002054356 A UA 2002054356A UA 2002054356 A UA2002054356 A UA 2002054356A UA 56458 A UA56458 A UA 56458A
- Authority
- UA
- Ukraine
- Prior art keywords
- solution
- blood
- sodium
- citric acid
- donor blood
- Prior art date
Links
- 238000004555 blood preservation Methods 0.000 title description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- 239000008103 glucose Substances 0.000 claims abstract description 8
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930024421 Adenine Natural products 0.000 claims abstract description 7
- 229960000643 adenine Drugs 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 5
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 15
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
- 239000001509 sodium citrate Substances 0.000 abstract description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 239000003755 preservative agent Substances 0.000 description 9
- 230000002335 preservative effect Effects 0.000 description 7
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical class [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000003633 blood substitute Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- RSGFPIWWSCWCFJ-VAXZQHAWSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O RSGFPIWWSCWCFJ-VAXZQHAWSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- -1 hydrogen ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NFIYTPYOYDDLGO-UHFFFAOYSA-N phosphoric acid;sodium Chemical class [Na].OP(O)(O)=O NFIYTPYOYDDLGO-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012065 two one-sided test Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Раствор для консервирования донорской крови содержит глюкозу, аденин, натрий лимоннокислый двузамещенный и натрий фосфорнокислый двузамещенный.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002054356A UA56458C2 (ru) | 2002-05-28 | 2002-05-28 | Раствор для консервирования донорской крови "адглюфоцит" |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002054356A UA56458C2 (ru) | 2002-05-28 | 2002-05-28 | Раствор для консервирования донорской крови "адглюфоцит" |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| UA56458A true UA56458A (ru) | 2003-05-15 |
| UA56458C2 UA56458C2 (ru) | 2005-05-16 |
Family
ID=34884559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002054356A UA56458C2 (ru) | 2002-05-28 | 2002-05-28 | Раствор для консервирования донорской крови "адглюфоцит" |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA56458C2 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103583508A (zh) * | 2013-11-25 | 2014-02-19 | 张超 | 一种液基细胞处理保存液的制备方法及其应用 |
-
2002
- 2002-05-28 UA UA2002054356A patent/UA56458C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA56458C2 (ru) | 2005-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6857291B2 (ja) | 赤血球の長期保存システムおよび使用方法 | |
| KR101548027B1 (ko) | 피로포스페이트를 함유하는 멸균된 투석 용액 | |
| US8771749B2 (en) | Stable bicarbonate ion-containing drug solution | |
| ES2595227T3 (es) | Composición de líquido de diálisis que comprende sustancias inhibidoras de la cristalización | |
| US6214802B1 (en) | Peritoneal dialysis fluid | |
| JP2008529550A (ja) | 赤血球の保存のための組成物及び方法 | |
| JP2008502722A (ja) | 重炭酸塩ベースの腹膜透析溶液 | |
| EP0510185B1 (en) | Blood platelet storage medium | |
| DK165734B (da) | Dialysevaedske | |
| US6241943B1 (en) | Use of a solution comprising glucose for peritoneal dialysis having reduced formation of age products | |
| CN106135195A (zh) | 含有精氨酸的组合物和用于处理红细胞的方法 | |
| CN112314593A (zh) | 一种适用于病毒样本常温保存的保存液及其制备方法 | |
| KR20080020600A (ko) | 복막 투석 유체 | |
| CN1186596A (zh) | 血液保存液 | |
| US5780438A (en) | Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents and physiological salts | |
| UA56458A (ru) | Раствор для консервирования донорской крови "адглюфоцит" | |
| CN110267534B (zh) | 器官保存和/或灌注溶液 | |
| JPH05504766A (ja) | プリン誘導体及びグルタチオンで安定化されたポリヘモグロビン | |
| Cancarini et al. | Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate | |
| US3703438A (en) | Method for the stabilization of blood | |
| CN108310005A (zh) | 一种抗腹膜纤维化的腹膜透析液 | |
| Kanagasundaram et al. | Massive haemoperitoneum due to rupture of splenic infarct during CAPD. | |
| UA56459A (ru) | Гемоконсервант "лактадглюфоцит" | |
| Knowles | Transfusion products | |
| Thomas et al. | (208) Minimally Invasive Lung Transplantation Improves Post-Operative Pulmonary Function and Reduces Opiate Requirements |